Newborn addiction: an unintended consequence of MAT

Summary and Analysis

In an article appearing in The Jackson Sun on September 18, 2017, Lisa Piercey, MD, MBA, a pediatrician, Executive Vice President for West Tennessee Healthcare and a board member for Aspell Recovery Center, identifies an unintended consequence associated with Medication-Assisted Treatment (MAT).

Excerpted from The Jackson Sun

“However, increasingly, cases of neonatal abstinence are the result of mothers participating in medication-assisted treatment (MAT) programs for opioid addiction, using prescribed drugs like buprenorphine (known commercially as Subutex or Suboxone) or sometimes methadone. Medication-assisted treatment can be an effective approach to treating opioid dependence, when combined with behavioral therapy, social support and after-care services; however, while most agree that MAT drugs do reduce withdrawal symptoms and cravings, controversy exists in the medical community related to substituting one addictive substance for another, as well as ideal duration of therapy.”